Potential Policy Changes that Could Upend Prescription Drug Pricing
On November 3, 2021, Congress introduced a working draft of the Build Back Better (BBB) Act. This legislation includes proposals that could drive some of the most material changes in drug pricing in the history of the Medicare Parts B and D programs. The changes are sweeping, with potential for some—such as inflation rebates—to be … Read more